AlphaLife Sciences expands its presence by joining BIO HK 2024, showcasing GenAI-powered solutions for clinical research at this leading biotech event.
At the 2024 SAPA-DC Annual Conference, AlphaLife Sciences CEO Sharon Chen highlighted AuroraPrime, a GenAI-powered platform that automates clinical trial processes. Tools like AuroraPrime Create and AuroraPrime Comprehend streamline document drafting and data monitoring, driving innovation in clinical research through GenAI and strategic partnerships.